Genetic variants reducing MTR gene expression increase the risk of congenital heart disease in Han Chinese populations
Open Access
- 24 June 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (11) , 733-742
Abstract
Elevated homocysteine levels are known to be a risk factor for congenital heart disease (CHD), but the mechanism underlying this effect is unknown. During early embryonic development, homocysteine removal is dictated exclusively by the MTR activity. To examine the role of MTR in CHD risk, we identified genetic variants in MTR and investigated the mechanisms that affect its expression levels and that increase the risk of CHD in Chinese populations. The association between regulatory variants of the MTR gene and CHD was examined in three independent case–control studies in a total of 2340 patients with CHD and 2270 controls. The functional consequences of these variants were demonstrated using dual-luciferase assays, real-time polymerase chain reaction (PCR), electrophoretic mobility shift assays, surface plasma resonance, chromatin immunoprecipitation, and bisulfite sequencing, as well as by a group of predicted microRNAs using a gene reporter system. Two regulatory variants of MTR, −186T>G and +905G>A, were associated with an increased risk of CHD in both the separate and combined case–control studies (−186GG P = 1.32 × 10−9; +905AA P = 6.35 × 10−14). Compared with the major allele, the −186G allele exhibited significantly lower promoter activity, decreased hnRNA and mRNA levels, reduced transcription factor binding affinity, and a more highly methylated promoter. The +905A allele exhibited a statistically stronger binding affinity to functional microRNAs that down regulate MTR expression at the translational level. Both of the minor alleles were correlated with elevated plasma homocysteine concentrations, indicating a genetic component for hyperhomocysteinaemia. Regulatory variants of the MTR gene increase CHD risk by reducing MTR expression and inducing the homocysteine accumulation and elevation.Keywords
This publication has 29 references indexed in Scilit:
- The changing epidemiology of congenital heart diseaseNature Reviews Cardiology, 2010
- The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysisQJM: An International Journal of Medicine, 2007
- Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementationEuropean Heart Journal, 2006
- Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genesAmerican Journal of Medical Genetics Part A, 2005
- Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase geneJournal of Medical Genetics, 2005
- Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriageThe American Journal of Clinical Nutrition, 2005
- Association between 5,10-Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Conotruncal Heart DefectsClinical Chemistry and Laboratory Medicine (CCLM), 2003
- The incidence of congenital heart diseaseJACC, 2002
- Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart diseaseCardiovascular Research, 2001
- Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformationsAmerican Journal of Obstetrics and Gynecology, 2001